An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder [Corrigendum]
Citrome L, Graham C, Simmons A, et al. Neuropsychiatr Dis Treat. 2021;17:2885–2904. The authors have advised there is an error in Figure 1C on page 2894. The key “OLZ/SAM” should read “Olanzapine + samidorphan 10 mg” and “Olanzapine&rdq...
Enregistré dans:
Auteurs principaux: | Citrome L, Graham C, Simmons A, Jiang Y, Todtenkopf MS, Silverman B, DiPetrillo L, Cummings H, Sun L, McDonnell D |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2f956761b90540fb83ae4e6a7146f4e3 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
An Evidence-Based Review of OLZ/SAM for Treatment of Adults with Schizophrenia or Bipolar I Disorder
par: Citrome L, et autres
Publié: (2021) -
A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future
par: Citrome L, et autres
Publié: (2019) -
Comparación del efecto de la terapia prolongada con antipsicóticos atípicos o convencionales en la incidencia de diabetes mellitus 2: Revisión sistemática y metaanálisis
par: Sapunar Z,Jorge, et autres
Publié: (2009) -
Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
par: Ward K, et autres
Publié: (2019) -
One-Year Course of Olanzapine-Induced Diabetic Ketoacidosis: A Case Report
par: Mohammed Zain Ulabedin Adhoni, et autres
Publié: (2021)